Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARIA: Aliskiren Effects on Albuminuria in Non-diabetic Nephropathy
NCT01302899Phase 2Terminated
- Sponsor
- Novartis
- Start
- Jan 2011
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aliskiren in Non-diabetic nephropathy, sponsored by Novartis. Started Jan 2011; status: terminated.
02
Drugs
aliskiren
03
Conditions
Non-diabetic nephropathy
Beyond the preview
Go deeper on NCT01302899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01302899.